Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

A gain in chromosome 1q (+1q) is among the most common cytogenetic abnormalities in multiple myeloma (MM). It is unclear whether +1q is independently associated with decreased overall survival (OS). The objective of this study was to evaluate the impact of +1q on clinical characteristics, treatment...

詳細記述

保存先:
書誌詳細
出版年:Blood Adv
主要な著者: Abdallah, Nadine, Greipp, Patricia, Kapoor, Prashant, Gertz, Morie A., Dispenzieri, Angela, Baughn, Linda B., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Go, Ronald S., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Lin, Yi, Leung, Nelson, Kourelis, Taxiarchis, Warsame, Rahma, Siddiqui, Mustaqeem, Lust, John, Kyle, Robert A., Bergsagel, Leif, Ketterling, Rhett, Rajkumar, S. Vincent, Kumar, Shaji K.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Clinical Trials and Observations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422105/
https://ncbi.nlm.nih.gov/pubmed/32750129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002218
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料